Zota Health Care LImited — PPTs, 06-11-2025: Investor Presentation

Zota Health Care's Davaindia retail generic pharmacy is its primary growth engine, now boasting 2,055+ stores (1,207 COCO, 848 FOFO) as of H1FY26. For H1FY26, total revenue from operations was ₹232.53 Cr, with Davaindia contributing 73%. The company reported a gross profit of ₹134.95 Cr (58% margin) and an operating profit of ₹10.28 Cr (4.4% margin), though it saw a net loss of ₹29.97 Cr.

Davaindia's Gross Merchandise Value (GMV) hit ₹194.81 Cr in H1FY26. Strategic focus areas include expanding Davaindia's COCO store network in dense urban areas, increasing marketing efforts, and enhancing the supply chain with hyperlocal delivery via mobile app. The company also aims to grow its product portfolio, particularly in chronic therapies and OTC segments, bolstered by recent acquisitions in the Everyday Herbal Group. Management remains focused on making quality healthcare affordable and accessible, leveraging Davaindia's strong positioning in India's growing organized pharmacy retail market.